{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:35:07Z","timestamp":1791272107417,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1997,10,1]],"date-time":"1997-10-01T00:00:00Z","timestamp":875664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,10,1]],"date-time":"1997-10-01T00:00:00Z","timestamp":875664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology and Immunopathology"],"published-print":{"date-parts":[[1997,10]]},"DOI":"10.1006\/clin.1997.4420","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T11:45:11Z","timestamp":1032176711000},"page":"16-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":205,"title":["IL-6: Insights into Novel Biological Activities"],"prefix":"10.1006","volume":"85","author":[{"given":"Beverly E.","family":"Barton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/clin.1997.4420_II974420C1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/324073a0","article-title":"Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin","volume":"324","author":"Hirano","year":"1986","journal-title":"Nature"},{"key":"10.1006\/clin.1997.4420_II974420C2","first-page":"3633","article-title":"Human chromosome 7 carries the \u03b22","volume":"84","author":"Sehgal","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4420_II974420C3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/j.1460-2075.1989.tb03362.x","article-title":"Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationship to interleukin-6 and granulocyte colony stimulating factor","volume":"8","author":"Leutz","year":"1989","journal-title":"EMBO"},{"key":"10.1006\/clin.1997.4420_II974420C4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0167-5699(90)90139-Z","article-title":"Haemopoietic receptors and helical cytokines","volume":"11","author":"Bazan","year":"1990","journal-title":"Immunol. Today"},{"key":"10.1006\/clin.1997.4420_II974420C5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(89)90438-8","article-title":"Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130","volume":"58","author":"Taga","year":"1989","journal-title":"Cell"},{"key":"10.1006\/clin.1997.4420_II974420C6","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1126\/science.8390097","article-title":"LIFR\u03b2 and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor","volume":"260","author":"Davis","year":"1993","journal-title":"Science"},{"key":"10.1006\/clin.1997.4420_II974420C7","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.1542794","article-title":"The IL-6 signal transducer, gp130: An oncostatin M receptor and affinity converter for the LIF receptor","volume":"255","author":"Gearing","year":"1992","journal-title":"Science"},{"key":"10.1006\/clin.1997.4420_II974420C8","first-page":"61","article-title":"Oncostatin M binds the high-affinity leukemia inhibitory factor receptor","volume":"4","author":"Gearing","year":"1992","journal-title":"New Biol."},{"key":"10.1006\/clin.1997.4420_II974420C9","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1002\/j.1460-2075.1994.tb06802.x","article-title":"Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction","volume":"13","author":"Hilton","year":"1994","journal-title":"EMBO J."},{"key":"10.1006\/clin.1997.4420_II974420C10","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.4049\/jimmunol.151.5.2555","article-title":"Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction","volume":"151","author":"Yin","year":"1993","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C11","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1126\/science.8511589","article-title":"IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase","volume":"260","author":"Murakami","year":"1993","journal-title":"Science"},{"key":"10.1006\/clin.1997.4420_II974420C12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.8272873","article-title":"Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 \u03b2 receptor components","volume":"263","author":"Stahl","year":"1994","journal-title":"Science"},{"key":"10.1006\/clin.1997.4420_II974420C13","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1073\/pnas.94.6.2478","article-title":"Impairment of antigen-specific antibody production in transgenic mice expressing a dominant-negative form of gp130","volume":"94","author":"Kumanogoh","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4420_II974420C14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.93.1.407","article-title":"Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders","volume":"93","author":"Yoshida","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4420_II974420C15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1084\/jem.175.4.1151","article-title":"Interleukin 6 is a permissive factor for monocytic colony formation by human hematopoietic progenitor cells","volume":"175","author":"Jansen","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4420_II974420C16","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1128\/iai.63.6.2262-2268.1995","article-title":"IL-6 deficient mice are highly susceptible toL. monocytogenes","volume":"63","author":"Dalrymple","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1006\/clin.1997.4420_II974420C17","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1128\/iai.65.6.2339-2345.1997","article-title":"Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice","volume":"65","author":"Suzuki","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1006\/clin.1997.4420_II974420C18","doi-asserted-by":"crossref","unstructured":"F. A. Houssiau, P. G. Coulie, D. Olive, J. Van Snick, Synergistic activation of human T cells by interleukin 1 and interleukin 6, Eur. J. Immunol. 18, 1988","DOI":"10.1002\/eji.1830180427"},{"key":"10.1006\/clin.1997.4420_II974420C19","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1073\/pnas.84.21.7629","article-title":"B-cell-stimulatory factor 2 (\u03b22","volume":"84","author":"Garman","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4420_II974420C20","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.4049\/jimmunol.141.5.1556","article-title":"Interferon-\u03b22","volume":"141","author":"Tosato","year":"1988","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C21","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.167.3.1253","article-title":"B cell stimulating factor 2\/interleukin 6 is a costimulant for human thymocytes and T lymphocytes","volume":"167","author":"Lotz","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4420_II974420C22","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.4049\/jimmunol.141.11.3868","article-title":"Human T cell activation with phytohemagglutinin","volume":"141","author":"Cueppens","year":"1988","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jlb.51.3.237","article-title":"Synergism of interleukin 6 and 1\u03b1,25-dihydroxyvitamin D3","volume":"51","author":"Duits","year":"1992","journal-title":"J. Leukocyte Biol."},{"key":"10.1006\/clin.1997.4420_II974420C24","first-page":"412","article-title":"Anti-IL-6 antibodies suppress myeloid cell production and the generation of CFU-c in long term bone marrow cultures","volume":"20","author":"Hudak","year":"1992","journal-title":"Exp. Hematol."},{"key":"10.1006\/clin.1997.4420_II974420C25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1182\/blood.V73.1.108.108","article-title":"In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs","volume":"73","author":"Ulich","year":"1989","journal-title":"Blood"},{"key":"10.1006\/clin.1997.4420_II974420C26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4049\/jimmunol.140.2.508","article-title":"B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes","volume":"140","author":"Takai","year":"1988","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C27","first-page":"203","article-title":"Interleukin-6 is the principal cytolytic T lymphocyte differentiation factor for thymocytes in human leukocyte conditioned medium","volume":"4","author":"Ming","year":"1989","journal-title":"J. Mol. Cell. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0008-8749(91)90128-X","article-title":"Interleukin-6 is constitutively produced by human CTL clones and is required to maintain their cytolytic function","volume":"138","author":"Galandrini","year":"1991","journal-title":"Cell. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C29","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.4049\/jimmunol.151.6.2895","article-title":"Heterogeneous mechanisms of human cytotoxic T lymphocyte generation","volume":"151","author":"Bass","year":"1993","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C30","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4049\/jimmunol.143.4.1206","article-title":"IFN-\u03b22","volume":"143","author":"Luger","year":"1989","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C31","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1128\/iai.65.6.2448-2450.1997","article-title":"Efficient immunity againstLeishmania major","volume":"65","author":"Moskowitz","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1006\/clin.1997.4420_II974420C32","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/eji.1830211006","article-title":"Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis","volume":"21","author":"Mihara","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1084\/jem.167.2.332","article-title":"The essential role of B cell stimulatory factor 2 (BSF-2\/IL-6) for the terminal differentiation of B cells","volume":"167","author":"Muraguchi","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4420_II974420C34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1084\/jem.157.2.583","article-title":"B cell growth factor (BCGF) and B cell differentiation factor from human T hybridomas","volume":"157","author":"Okada","year":"1983","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4420_II974420C35","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.4049\/jimmunol.141.9.3072","article-title":"Human recombinant IL-6\/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo","volume":"141","author":"Takatsuki","year":"1988","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C36","first-page":"175","article-title":"A growth factor for B cell hybridomas produced by human monocytes","volume":"10","author":"Aarden","year":"1985","journal-title":"Lymphokines"},{"key":"10.1006\/clin.1997.4420_II974420C37","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/eji.1830171004","article-title":"Production of hybridoma growth factor by human monocytes","volume":"17","author":"Aarden","year":"1987","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1749-6632.1989.tb24012.x","article-title":"Hybridoma growth factor","volume":"557","author":"Aarden","year":"1989","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1006\/clin.1997.4420_II974420C39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.3492764","article-title":"Human \u03b22","volume":"235","author":"Sehgal","year":"1987","journal-title":"Science"},{"key":"10.1006\/clin.1997.4420_II974420C40","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.86.19.7547","article-title":"IgG1 plasmacytosis in interleukin 6 transgenic mice","volume":"86","author":"Suematsu","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4420_II974420C41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/1043-4666(91)90002-U","article-title":"Interleukin-6 administration has no acute hemodynamic or hematologic effects in the dog","volume":"3","author":"Preiser","year":"1991","journal-title":"Cytokine"},{"key":"10.1006\/clin.1997.4420_II974420C42","first-page":"403","article-title":"Comparison ofin vivo","volume":"7","author":"Neta","year":"1988","journal-title":"Lymphokine Res."},{"key":"10.1006\/clin.1997.4420_II974420C43","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1182\/blood.V75.8.1602.1602","article-title":"In vivo","volume":"75","author":"Asano","year":"1990","journal-title":"Blood"},{"key":"10.1006\/clin.1997.4420_II974420C44","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/S0021-9258(18)52293-6","article-title":"Induction of phospholipase A2","volume":"266","author":"Crowl","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1006\/clin.1997.4420_II974420C45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1139\/y83-086","article-title":"Involvement of circulating phospholipase A2","volume":"6","author":"Vadas","year":"1983","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1006\/clin.1997.4420_II974420C46","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF02028289","article-title":"Extracellular phospholipase A2","volume":"24","author":"Vadas","year":"1988","journal-title":"Agents Actions"},{"key":"10.1006\/clin.1997.4420_II974420C47","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.4049\/jimmunol.143.11.3517","article-title":"IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice","volume":"143","author":"Aderka","year":"1989","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C48","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V81.8.2076.2076","article-title":"Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-\u03b1","volume":"81","author":"Aderka","year":"1993","journal-title":"Blood"},{"key":"10.1006\/clin.1997.4420_II974420C49","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.4049\/jimmunol.146.7.2316","article-title":"Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6","volume":"146","author":"Ulich","year":"1991","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jlb.52.1.125","article-title":"Inhibitory role of interleukin-6 in macrophage proliferation","volume":"52","author":"Riedy","year":"1992","journal-title":"J. Leukocyte Biol."},{"key":"10.1006\/clin.1997.4420_II974420C51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/cyto.1996.0153","article-title":"Adenosine increases interleukin 6 release and decreases tumor necrosis factor release from rat adrenal zona glomerulosa cells, ovarian cells, anterior pituitary cells, and peritoneal macrophages","volume":"9","author":"Ritchie","year":"1997","journal-title":"Cytokine"},{"key":"10.1006\/clin.1997.4420_II974420C52","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0022-3565(25)38610-6","article-title":"Discrimination of A12in vivo","volume":"268","author":"Barrett","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/clin.1997.4420_II974420C53","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1172\/JCI116884","article-title":"The antiinflammatory mechanism of methotrexate","volume":"92","author":"Cronstein","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1997.4420_II974420C54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1128\/iai.61.1.97-102.1993","article-title":"Interleukin-6 production in a murine model ofPneumocystis carinii","volume":"61","author":"Chen","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1006\/clin.1997.4420_II974420C55","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1128\/iai.60.10.4245-4252.1992","article-title":"Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages","volume":"60","author":"Bermudez","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1006\/clin.1997.4420_II974420C56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jlb.52.2.197","article-title":"Interleukin-6 in mouse hypersensitivity pneumonitis: Changes in lung free cells following depletion of endogenous IL-6 or direct administration of IL-6","volume":"52","author":"Denis","year":"1992","journal-title":"J. Leukocyte Biol."},{"key":"10.1006\/clin.1997.4420_II974420C57","first-page":"1097","article-title":"Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation","volume":"138","author":"Ulich","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1006\/clin.1997.4420_II974420C58","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0021-9258(18)52202-X","article-title":"Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1\/erythroid potentiating factor activity (TIMP-1\/EPA)","volume":"266","author":"Lotz","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1006\/clin.1997.4420_II974420C59","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1128\/iai.61.4.1496-1499.1993","article-title":"The protective role of IL-6 in a septic shock model","volume":"61","author":"Barton","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1006\/clin.1997.4420_II974420C60","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1128\/iai.64.3.714-718.1996","article-title":"Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model","volume":"64","author":"Barton","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1006\/clin.1997.4420_II974420C61","doi-asserted-by":"crossref","first-page":"9756","DOI":"10.1016\/S0021-9258(18)47999-9","article-title":"Distinct sets of acute phase plasma proteins are stimulated by separate human hepatocyte-stimulating factors and monokines in rat hepatoma cells","volume":"262","author":"Baumann","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1006\/clin.1997.4420_II974420C62","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.4049\/jimmunol.151.3.1456","article-title":"Suramin inhibits the stimulation of acute phase protein genes by IL-6-type cytokines in rat hepatoma cells","volume":"151","author":"Baumann","year":"1993","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C63","first-page":"141","article-title":"Interleukin-1 and interleukin-6 act synergistically to stimulate the release of adrenocorticotropic hormonein vivo","volume":"10","author":"Perlstein","year":"1991","journal-title":"Lymphokine Cytokine Res."},{"key":"10.1006\/clin.1997.4420_II974420C64","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-2249.1990.tb08114.x","article-title":"Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal gland cells","volume":"79","author":"Salas","year":"1990","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C65","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.4049\/jimmunol.145.12.4185","article-title":"Anti-IL-6 monoclonal antibodies protect against lethalEscherichia coli","volume":"145","author":"Starnes","year":"1990","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C66","doi-asserted-by":"crossref","first-page":"19698","DOI":"10.1016\/S0021-9258(18)41831-5","article-title":"High levels of \u201ccomplexed\u201d interleukin-6 in human blood","volume":"267","author":"May","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1006\/clin.1997.4420_II974420C67","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.4049\/jimmunol.151.6.3225","article-title":"Antibodies chaperone circulating IL-6","volume":"151","author":"May","year":"1993","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C68","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/1043-4666(90)90019-P","article-title":"IL-3 and IL-6 do not induce bone resorption in vitro","volume":"2","author":"Barton","year":"1990","journal-title":"Cytokine"},{"key":"10.1006\/clin.1997.4420_II974420C69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.5650060103","article-title":"Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae","volume":"6","author":"Al-Humidan","year":"1991","journal-title":"J. Bone Miner. Res."},{"key":"10.1006\/clin.1997.4420_II974420C70","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","article-title":"IL-6 is produced by osteoblasts and induces bone resorption","volume":"145","author":"Ishimi","year":"1990","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C71","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/0006-291X(89)90851-6","article-title":"Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis","volume":"162","author":"Lowik","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/clin.1997.4420_II974420C72","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/1043-4666(94)90060-4","article-title":"Interleukin 6 production in fetal rat long bone cultures is correlated with PGE2","volume":"6","author":"Bertolini","year":"1994","journal-title":"Cytokine"},{"key":"10.1006\/clin.1997.4420_II974420C73","first-page":"221","article-title":"Effects of recombinant human interleukin-6 administration on bone in rhesus monkeys","volume":"13","author":"Binkley","year":"1994","journal-title":"J. Bone Miner. Res."},{"key":"10.1006\/clin.1997.4420_II974420C74","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/jbmr.5650101013","article-title":"In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis","volume":"10","author":"Most","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1006\/clin.1997.4420_II974420C75","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI115668","article-title":"17\u03b2-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens","volume":"89","author":"Girasole","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1997.4420_II974420C76","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/jbmr.5650100914","article-title":"Endogenous bone-resorbing factors in estrogen deficiency: Cooperative effects of IL-1 and IL-6","volume":"10","author":"Miyaura","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1006\/clin.1997.4420_II974420C77","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","article-title":"Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6","volume":"90","author":"Tamura","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4420_II974420C78","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.144.11.4226","article-title":"IL-6 stimulates osteoclast-like multinucleated cell formation in long term human bone marrow cultures by inducing IL-1 release","volume":"144","author":"Kurihara","year":"1990","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C79","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.182.5.1461","article-title":"Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors","volume":"182","author":"Udagawa","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4420_II974420C80","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI115584","article-title":"Interleukin 6. A potential autocrine\/paracrine factor in Paget's disease of bone","volume":"89","author":"Roodman","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1997.4420_II974420C81","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0049-0172(94)90043-4","article-title":"Biology of the osteoclast in Paget's disease","volume":"23","author":"Roodman","year":"1994","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1006\/clin.1997.4420_II974420C82","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jbmr.5650090111","article-title":"6 receptor, and IL-6 nuclear factor gene expression in Paget's disease","volume":"9","author":"Hoyland","year":"1994","journal-title":"J. Bone Miner. Res."},{"key":"10.1006\/clin.1997.4420_II974420C83","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Strassman","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1997.4420_II974420C84","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI116816","article-title":"Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia","volume":"92","author":"Strassman","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1997.4420_II974420C85","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/eji.1830230824","article-title":"Cachexia and the acute-phase response in inflammation are regulated by interleukin-6","volume":"23","author":"Oldenburg","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1997.4420_II974420C86","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/1043-4666(93)90058-D","article-title":"The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo","volume":"5","author":"Strassman","year":"1993","journal-title":"Cytokine"},{"key":"10.1006\/clin.1997.4420_II974420C87","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1210\/endo-128-5-2657","article-title":"Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice","volume":"128","author":"Black","year":"1991","journal-title":"Endocrinology"}],"container-title":["Clinical Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122997944202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122997944202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:11:27Z","timestamp":1758762687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090122997944202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["S0090122997944202"],"URL":"https:\/\/doi.org\/10.1006\/clin.1997.4420","relation":{},"ISSN":["0090-1229"],"issn-type":[{"value":"0090-1229","type":"print"}],"subject":[],"published":{"date-parts":[[1997,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-6: Insights into Novel Biological Activities","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/clin.1997.4420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1997  Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}